Contact this trialFirst, we need to learn more about you.
Protein Kinase Inhibitor
Immunotherapy with CFI-400945 for Breast Cancer
Recruiting1 awardPhase 2
Ottawa, Ontario
This trial is testing a new drug called CFI-400945 for breast cancer patients who have already had chemotherapy. The drug works by blocking a protein that helps cancer cells grow, potentially slowing down or killing the cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service